Europe

The International Society of Pharmacovigilance (ISoP) began in 2006 a process of regionalization through the creation of national chapters that could promote more effectively the ISoP throughout all different geographic areas with training activities and scientific meetings. National chapters soon evolved into chapters covering large geographic areas with common characteristics concerning pharmacovigilance and healthcare system in general (Middle East chapter, LATAM chapter, NASOP). This has favored local ISoP activities and even in countries that did not have enough members to create a national chapter. 

The ISoP annual meeting that took place in Verona (2022) marked an important step for re-gathering together and sharing experiences in pharmacovigilance after the slowdown caused by the COVID-19 pandemic. The opportunity to meet again in person in such a stimulating scientific context served as a springboard for new initiatives including the foundation of the ISoP European chapter. The European Chapter was officially launched at the ISoP mid-year symposium in Leiden on June 1^st, 2023.

In line with ISoP general aims, the ISoP European Chapter will specifically be engaged in promoting adhesion of all key European pharmacovigilance stakeholders to the ISoP. This aim will be pursued through scientific debate at webinar and face to face meetings, continuing education in pharmacovigilance and creation of EU research networks in pharmacovigilance, addressing preferentially but not exclusively drug safety issues of European interest.

The opportunities provided by the European chapter will be made available to all ISoP members, without distinction of geographical origin, with a view to a global collaboration that is traditionally envisaged by ISoP.